CTRI/2014/05/004629进行中（未招募）2 期
Clinical Evaluation of Vatari Guggulu Rasna Saptaka Kashaya and Brihat Saindhavadi Taila in the Management of Rheumatoid Arthritis - NI
CCRAS0 个研究点目标入组 240 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1). Patients of either sex with age between 20 and 60 years
- •2). Presence of any four out of the following seven criteria (according to 1987, revised criteria of American College of Rheumatology)
- •a. Morning stiffness: Stiffness in and around joints lasting one hour before Maximal improvement (More than 6 week duration).
- •b. Arthritis of three or more joints, at least three joint area, observed by Physician, having pain with soft tissue swelling or joint effusion, not just bony over growth, (more than 6 week duration).
- •c. Arthritis of hand joints, at least 1 area in wrist and hand is swollen (more than 6 week duration).
- •d. Symmetric arthritis (more than 6 week duration).
- •e. Presence of Rheumatoid Nodules
- •f. Serum Rheumatoid factor- positive
- •g. Typical radiographic changes of arthritis on PA view of hand & wrist radiograph that must include erosions or unequivocal bony decalcification, localized in or adjacent to involved joints.
- •3).Patients willing to give written informed consent to participate in the study for 12 weeks.
排除标准
- •1. Patients who have developed complications of Rheumatoid Arthritis e.g. Deformity of joints / bones, pleura-pericardial disease, or else.
- •2. Patients who are unable to walk without support and / or confined to wheel chair.
- •3. Patients with structural deformity as the complication of RA.
- •4. Patients with poorly controlled Hypertension ( >= 160/100 mmHg)
- •5. Patients suffering with Diabetes Mellitus
- •{Blood Sugar Fasting > 126 mg/dl).
- •6. Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis etc.
- •7. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
- •8. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •9. Symptomatic patients with clinical evidence of Heart failure.
- •10. Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (Uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.
- •11. Alcoholics and/or drug abusers.
- •12. H/o hypersensitivity to any of the trial drugs or their ingredients.
- •13. Pregnant / lactating woman.
- •14. Patients who have completed participation in any other clinical trial during the past six months.
- •15. Any other condition which the Investigator thinks may jeopardize the study.
研究者
相似试验
已完成
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of Arthritis knee.CTRI/2014/02/004388Central Council for Research in Ayurvedic Sciences180
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the patients of Diabetes Mellitus.CTRI/2012/03/002537Central Council for Research in Ayurvedic Sciences CCRAS150
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of High Blood Sugar.CTRI/2012/05/002646Department of AYUSH Ministry of Health Family Welfare Government of India150
尚未招募
不适用
EFFECT OF KANCHNAR GUGGULU IN BPHCTRI/2020/04/024703ot any Sponsor
尚未招募
1 期
Ayurvedic treatment of Osteoarthritis(Sandhigata vata)CTRI/2021/03/032221Ayurvedic and Unani Tibbia College and Hospital